These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 985377)
1. Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts. Skaper SD; Molden DP; Seegmiller JE Biochem Genet; 1976 Aug; 14(7-8):527-39. PubMed ID: 985377 [TBL] [Abstract][Full Text] [Related]
2. Functional differences in the catabolism of branched-chain L-amino acids in cultured normal and maple syrup urine disease fibroblasts. Schadewaldt P; Wendel U Biochem Med Metab Biol; 1989 Apr; 41(2):105-16. PubMed ID: 2719855 [TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids. Amaral AU; Wajner M Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033 [TBL] [Abstract][Full Text] [Related]
5. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Bridi R; Araldi J; Sgarbi MB; Testa CG; Durigon K; Wajner M; Dutra-Filho CS Int J Dev Neurosci; 2003 Oct; 21(6):327-32. PubMed ID: 12927581 [TBL] [Abstract][Full Text] [Related]
6. Blood and tissue branched-chain amino and alpha-keto acid concentrations: effect of diet, starvation, and disease. Hutson SM; Harper AE Am J Clin Nutr; 1981 Feb; 34(2):173-83. PubMed ID: 7211722 [TBL] [Abstract][Full Text] [Related]
7. Analysis of maple syrup urine disease in cell culture: use of substrates. Schadewaldt P; Beck K; Wendel U Clin Chim Acta; 1989 Sep; 184(1):47-56. PubMed ID: 2598467 [TBL] [Abstract][Full Text] [Related]
8. Study on established lymphoid cells in maple syrup urine disease. Correlation with clinical heterogeneity. Jinno Y; Akaboshi I; Katsuki T; Matsuda I Hum Genet; 1984; 65(4):358-61. PubMed ID: 6693123 [TBL] [Abstract][Full Text] [Related]
9. Quantification of Branched-Chain Amino Acids in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Piri-Moghadam H; Miller A; Pronger D; Vicente F; Charrow J; Haymond S; Lin DC Methods Mol Biol; 2022; 2546():65-81. PubMed ID: 36127579 [TBL] [Abstract][Full Text] [Related]
10. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro. Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137 [TBL] [Abstract][Full Text] [Related]
11. Maple syrup urine disease: branched-chain keto acid decarboxylation in fibroblasts as measured with amino acids and keto acids. Dancis J; Hutzler J; Cox RP Am J Hum Genet; 1977 May; 29(3):272-9. PubMed ID: 868873 [TBL] [Abstract][Full Text] [Related]
12. [Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children]. Kowalik A; Narojek L; Sykut-Cegielska J Rocz Panstw Zakl Hig; 2007; 58(1):95-101. PubMed ID: 17711097 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of branched-chain amino acid intake in children with maple syrup urine disease and methylmalonic aciduria. Parsons HG; Carter RJ; Unrath M; Snyder FF J Inherit Metab Dis; 1990; 13(2):125-36. PubMed ID: 2116544 [TBL] [Abstract][Full Text] [Related]
14. Case report: Aqueous and Vitreous amino-acid concentrations in a patient with maple syrup urine disease operated on rhegmatogenous retinal detachment. Kanakis MG; Michelakakis H; Petrou P; Koutsandrea C; Georgalas I BMC Ophthalmol; 2016 Oct; 16(1):170. PubMed ID: 27716111 [TBL] [Abstract][Full Text] [Related]
15. Intracellular levels and metabolism of leucine and alpha-ketoisocaproate in normal and maple syrup urine disease fibroblasts. Wendel U; Langenbeck U Biochem Med; 1984 Jun; 31(3):294-302. PubMed ID: 6477534 [TBL] [Abstract][Full Text] [Related]
16. On the mechanism of L-alloisoleucine formation: studies on a healthy subject and in fibroblasts from normals and patients with maple syrup urine disease. Schadewaldt P; Hammen HW; Dalle-Feste C; Wendel U J Inherit Metab Dis; 1990; 13(2):137-50. PubMed ID: 2116545 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease. Tavares RG; Santos CE; Tasca CI; Wajner M; Souza DO; Dutra-Filho CS J Neurol Sci; 2000 Dec; 181(1-2):44-9. PubMed ID: 11099711 [TBL] [Abstract][Full Text] [Related]
19. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease. Kindt E; Halvorsen S Am J Clin Nutr; 1980 Feb; 33(2):279-86. PubMed ID: 6101930 [TBL] [Abstract][Full Text] [Related]
20. Enzyme activity in classical and variant forms of maple syrup urine disease. Dancis J; Hutzler J; Snyderman SE; Cox RP J Pediatr; 1972 Aug; 81(2):312-20. PubMed ID: 5042489 [No Abstract] [Full Text] [Related] [Next] [New Search]